Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound

US9382553B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9382553-B2
Application numberUS-201213587826-A
CountryUS
Kind codeB2
Filing dateAug 16, 2012
Priority dateAug 16, 2011
Publication dateJul 5, 2016
Grant dateJul 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides for a genetically modified host cell capable of producing 1-deoxyxylulose 5-phosphate or 1-deoxy-D-xylulose 5-phosphate (DXP) (12), and optionally one or more DXP derived compounds, comprising: (a) a mutant RibB, or functional variant thereof, capable of catalyzing xylulose 5-phosphate and/or ribulose 5-phosphate to DXP, or (b) a YajO, or functional variant thereof, and a XylB, or functional variant thereof.

First claim

Opening claim text (preview).

We claim: 1. A genetically modified host cell capable of producing 1-deoxyxylulose 5-phosphate or 1-deoxy-D-xylulose 5-phosphate (DXP) comprising: a mutant 3,4-dihydroxy-2-butanone 4-phosphate synthase (RibB) comprising a polypeptide sequence that is identical to SEQ ID NO:1 except the polypeptide sequence comprises one or more of the following amino acid substitutions corresponding to substitutions in SEQ ID NO:1 selected from the group consisting of G108S, T88I, S89R, V109I, M182I, G92D, and T106I; wherein the host cell is a prokaryotic cell. 2. The host cell of claim 1 , wherein the host cell does not naturally comprise a gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase (dxs). 3. The host cell of claim 1 , wherein the host cell (a) further comprises a disruption in an endogenous gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase, or (b) further comprises a mutation in an endogenous gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase which reduces 1-deoxy-D-xylulose 5-phosphate synthase activity or reduces expression of said gene. 4. The host cell of claim 1 , wherein the host cell is capable of producing 2C-methyl-D-erythritol 4-phosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase. 5. The host cell of claim 1 , wherein the host cell is capable of producing 4-diphosphocytidyl-2C-methyl-D-erythritol, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase and a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase. 6. The host cell of claim 1 , wherein the host cell is capable of producing 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, and a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase. 7. The host cell of claim 1 , wherein the host cell is capable of producing 2C-methyl-D-erythritol 2,4-diphosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, and a 2C-methyl-D-erythritol 2,4-diphosphate synthase. 8. The host cell of claim 1 , wherein the host cell is capable of producing 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, and a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase. 9. The host cell of claim 1 , wherein the host cell is capable of producing isopentenyl pyrophosphate (IPP) and/or dimethylallyl pyrophosphate (DMAPP), and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase, and a 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase. 10. The host cell of claim 1 , wherein the host cell is capable of producing geranyl pyrophosphate (GPP) and optionally farnesyl pyrophosphate (FPP), and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase, a 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase, a GPP synthase and optionally a FPP synthase. 11. The host cell of claim 1 , wherein the host cell is capable of producing DXP derivatives, wherein said DXP derivatives are (i) isopentenol, geraniol, and optionally farnesol, or (ii) an isoprenyl alkanoate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase, a 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase, a GPP synthase, the corresponding enzymes for producing the DXP derivatives of (i) or (ii), and optionally a FPP synthase. 12. A genetically modified host cell capable of producing 1-deoxyxylulose 5-phosphate or 1-deoxy-D-xylulose 5-phosphate (DXP) comprising (a) an aldo/keto reductase (YajO) having the amino acid sequence of SEQ ID NO: 2, and (b) a xylulokinase (xylB) having the amino acid sequence of SEQ ID NO: 3, wherein the host cell (i) does not naturally comprise a gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase, or (ii) further comprises a disruption in an endogenous gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase, wherein said host cell is a prokaryotic cell, and wherein: (I) the host cell is capable of producing GPP and optionally FPP, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase, a 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase, a GPP synthase and optionally a FPP synthase; or (II) the host cell is capable of producing DXP derivatives, wherein said DXP derivatives are (i) isopentenol, geraniol, and optionally farnesol, or (ii) an isoprenyl alkanoate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, a 2C-methyl-D-erythritol 2,4-diphosphate synthase, a 2C-methyl-D-erythritol 2,4-cyclodiphosphate reductase, a 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase, a GPP synthase, the corresponding enzymes for producing the DXP derivatives of (i) or (ii), and optionally a FPP synthase. 13. The host cell of claim 12 , wherein the host cell does not naturally comprise a gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase. 14. The host cell of claim 12 , wherein the host cell further comprises a disruption in an endogenous gene encoding a 1-deoxy-D-xylulose 5-phosphate synthase. 15. The host cell of claim 12 , wherein the host cell is capable of producing 2C-methyl-D-erythritol 4-phosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase. 16. The host cell of claim 12 , wherein the host cell is capable of producing 4-diphosphocytidyl-2C-methyl-D-erythritol, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase and a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase. 17. The host cell of claim 12 , wherein the host cell is capable of producing 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, and a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase. 18. The host cell of claim 12 , wherein the host cell is capable of producing 2C-methyl-D-erythritol 2,4-diphosphate, and the host cell further comprises a 2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol 4-phosphate synthase, a 4-diphosphocytidyl-2C-methyl-D-erythritol kinase, and a 2C-methyl-D-erythr

Assignees

Inventors

Classifications

  • C12P5/007Primary

    containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00) · CPC title

  • C12P19/02Primary

    Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9382553B2 cover?
The present invention provides for a genetically modified host cell capable of producing 1-deoxyxylulose 5-phosphate or 1-deoxy-D-xylulose 5-phosphate (DXP) (12), and optionally one or more DXP derived compounds, comprising: (a) a mutant RibB, or functional variant thereof, capable of catalyzing xylulose 5-phosphate and/or ribulose 5-phosphate to DXP, or (b) a YajO, or functional variant thereo…
Who is the assignee on this patent?
Kirby James, Fortman Jeffrey L, Nishimoto Minobu, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12P5/007. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).